84180 Federal Register / Vol. 89, No. 203 / Monday, October 21, 2024 / Notices 

the White House Office of Science and 

Technology Policy on Scientific 

Integrity at https://obamawhitehouse.

archives.gov/sites/default/files/ 

microsites/ostp/scientific-integritymemo-12172010.pdf, all Federal 

agencies must establish a scientific 

integrity policy. The requirements of 

this policy are derived from the 2022 

National Science and Technology 

Council (NSTC) Report of the Scientific 

Integrity Fast Track Action Committee, 

Protecting the Integrity of Government 

Science, at https://www.whitehouse.gov/ 

wp-content/uploads/2022/01/01-22-

Protecting_the_Integrity_of_

Government_Science.pdf, and align 

with the principles set forth in the 

NSTC guidance document, A 

Framework for Federal Scientific 

Integrity Policy and Practice, at https:// 

www.whitehouse.gov/wp-content/ 

uploads/2023/01/01-2023-Frameworkfor-Federal-Scientific-Integrity-Policyand-Practice.pdf. 

This policy is established in 

accordance with: 

1. Public Law 111–358—The America

COMPETES Reauthorization Act of

2010, Section 103, as amended 

2. Public Law 115–435—The

Foundations for Evidence-based

Policymaking Act of 2018 

3. Public Law 106–554—The

Information Quality Act of 2000

4. 67 FR 8451—OMB Guidelines for

Ensuring and Maximizing the

Quality, Objectivity, Utility, and 

Integrity of Information 

Disseminated by Federal Agencies 

5. 70 FR 2664—OMB Final Information

Quality Bulletin for Peer Review

6. 65 FR 76260–76264—Federal Policy

on Research Misconduct

7. Public Law 101–12—The

Whistleblower Protection Act

(WPA) of 1989, as amended 

8. 41 U.S.C. part 4712—The National

Defense Authorization Act,

Enhancement of contractor 

protection from reprisal for 

disclosure of certain information 

9. 5 U.S.C. part 13103 et seq.—The

Ethics in Government Act of 1978,

as amended, and 5 CFR parts 2634 

and 2635, Executive Branch 

Financial Disclosure, Qualified 

Trusts, and Certificates of 

Divestiture and Standards of Ethical 

Conduct for Employees of the 

Executive Branch 

10. 18 U.S.C. parts 201–209—Statutes

regarding Bribery, Graft and

Conflicts of Interest

11. 5 CFR parts 5501 and 5502—

Supplemental Standards of Ethical

Conduct for Employees of the

Department of Health and Human

Services

12. 5 U.S.C. Ch. 10—The Federal

Advisory Committee Act of 1972

13. 45 CFR part 73—Standards of

Conduct

14. 5 CFR part 735—Employee

Responsibilities and Conduct

15. 45 CFR part 46—HHS Protection of

Human Subjects Regulation

16. PPD 19—Protecting Whistleblowers

with Access to Classified

Information, 2012

17. M–20–12—OMB Phase 4

Implementation of the Foundations

for Evidence-Based Policymaking

Act of 2018: Program Evaluation

Standards and Practices

18. 42 CFR part 93—Public Health

Service Policies on Research

Misconduct

19. 10 U.S.C. part 1034, made applicable

to the Public Health Service

Commissioned Corps through 42

U.S.C. 213a(a)(18) and implemented

by Commissioned Corps Directive

(CCD) 121.06

20. Public Law No 117–328—Health

Extenders, Improving Access to

Medicare, Medicaid, and CHIP, and

Strengthening Public Health Act of

2022, Division FF, Title II, Section

2321

21. Public Law No 117–167—CHIPS and

Science Act of 2022, Title VI,

Subtitle D, Section 10631

Dated: October 15, 2024. 

Lawrence A. Tabak, 

Principal Deputy Director, National Institutes 

of Health. 

[FR Doc. 2024–24225 Filed 10–18–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

Periodically, the Substance Abuse and 

Mental Health Services Administration 

(SAMHSA) will publish a summary of 

information collection requests under 

OMB review, in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

chapter 35). To request a copy of these 

documents, call the SAMHSA Reports 

Clearance Officer at (240) 276–0166. 

Project: State Opioid Response (SOR)/ 

Tribal Opioid Response (TOR) Program 

Instrument (OMB No. 0930–0384)— 

Revision 

SAMHSA is requesting approval to 

modify its existing SOR/TOR Program 

Instrument by (1) broadening language 

from ‘naloxone’ to ‘naloxone and other 

opioid overdose reversal medications’ 

due to the availability of new FDAapproved non-naloxone overdose 

reversal medications; (2) broadening 

language from ‘fentanyl test strips’ to 

‘drug checking technologies as directed 

by SAMHSA due to the availability of 

new drug checking technology, 

including test strips for other emerging 

substances; (3) adding five questions to 

collect treatment and recovery support 

data that were previously reported 

biannually in the performance progress 

reports; (4) adding one question to 

collect data on clients who received 

contingency management for the 

treatment of stimulant use disorder; (5) 

adding a sub-recipient entity inventory 

table to collect expenditure data for 

each grant sub-recipient in response to 

the Consolidated Appropriations Act, 

2023 (42 U.S.C. 300x–52(a)); (6) 

combining four questions with similar 

themes into two questions for clarity; (7) 

removing question 12 because it is 

comprised of more than one question 

with several different ideas, making it 

unsuited for this instrument; and (8) 

adding one question at the request of the 

Office of National Drug Control Policy 

(ONDCP) to collect information on 

Congressionally mandated and 

programmatic activities, and to comply 

with reporting requirements. The 

program-level information is collected 

quarterly for questions 1 to 13b, and 

annually for the sub-recipient entity 

inventory table, and entered and stored 

in SAMHSA’s Performance 

Accountability and Reporting System 

(SPARS), which is a real-time, 

performance management system that 

captures information on the SAMHSAfunded substance use and substance use 

disorder prevention, harm reduction, 

treatment, and recovery support 

services, and mental health services 

delivered in the United States. 

Continued approval of this information 

collection will allow SAMHSA to 

continue to meet Government 

Performance and Results Modernization 

Act of 2010 reporting requirements that 

quantify the effects and 

accomplishments of its discretionary 

grant programs. 

The SOR/TOR programs are 

authorized under the Further 

Consolidated Appropriations Act, 2024, 

Division D, Title II, and section 1003 of 

the 21st Century Cures Act [Public Law 

114–255] (42 U.S.C. 290ee–3a), as 

amended. SAMHSA anticipates 189 

recipients (states, territories, and tribal 

entities) will participate in these grant 

programs. Grantee-level data will 

include information related to: reported 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 89, No. 203 / Monday, October 21, 2024 / Notices 84181 

overdose reversals; the purchase and 

distribution of naloxone and other 

opioid overdose reversal medications; 

types of entities that distribute naloxone 

and other opioid overdose reversal 

medications; training on recognizing an 

opioid overdose and appropriate use of 

naloxone and other opioid overdose 

reversal medications; implementation of 

prevention and education activities; the 

purchase and distribution of drug 

checking technologies as directed by 

SAMHSA; treatment services for opioid 

use disorder (OUD) and stimulant use 

disorder; types of recovery support 

services; and the expenditure amounts 

for each SOR and TOR grant subrecipient. This grantee-level information 

will be collected quarterly for questions 

1 to 13b, and annually for the subrecipient entity inventory table. 

The revisions to the tool will continue 

to enable SAMHSA to better assess 

grantee accountability and performance 

on the required prevention, education, 

harm reduction, treatment, and recovery 

support activities for the SOR/TOR 

programs. The revisions will continue to 

assist SAMHSA in providing 

comprehensive data on the full range of 

required activities to inform 

Congressionally mandated reports for 

the SOR program. 

The Center for Substance Abuse 

Treatment (CSAT) anticipates that the 

time required to collect and report the 

program-level information is 

approximately 33 minutes per response. 

Since the submission of the previous 

OMB package, there has been an 

increase in the number of respondents. 

The estimated burden associated with 

the program-level instrument includes 

an adjustment to reflect the current 

number of grantees. 

TABLE 1—ESTIMATE OF ANNUALIZED HOUR BURDEN FOR SOR/TOR GRANTEES

SAMHSA data collection Number of 

respondents 

Responses 

per 

respondent 

Total 

number of 

responses 

Burden 

hours per 

response 

Total 

burden 

hours 

Hourly 

wage 1

Total 

wage 

cost 

Grantee-Level Instrument ..................................................... 189 4 756 .30 226.80 $28.89 $6,552.25 

Grantee-Level Instrument ..................................................... 189 1 189 .25 47.25 28.89 1,365.05 

Total ............................................................................... 378 5 945 .55 274.05 28.89 7,917.30 

1The hourly wage estimate is $28.89 based on the Occupational Employment and Wages, Mean Hourly Wage Rate for 21–1018 Substance Abuse, Behavioral Disorder, and Mental Health Counselors= $28.89/hr. as of May 2023 (https://www.bls.gov/oes/current/oes211018.htm Accessed on September 23, 2024.) 

Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

Krishna Palipudi, 

Social Science Analyst. 

[FR Doc. 2024–24250 Filed 10–18–24; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Federal Emergency Management 

Agency 

[Docket ID FEMA–2024–0002] 

Final Flood Hazard Determinations 

AGENCY: Federal Emergency 

Management Agency, Department of 

Homeland Security. 

ACTION: Notice. 

SUMMARY: Flood hazard determinations, 

which may include additions or 

modifications of Base Flood Elevations 

(BFEs), base flood depths, Special Flood 

Hazard Area (SFHA) boundaries or zone 

designations, or regulatory floodways on 

the Flood Insurance Rate Maps (FIRMs) 

and where applicable, in the supporting 

Flood Insurance Study (FIS) reports 

have been made final for the 

communities listed in the table below. 

The FIRM and FIS report are the basis 

of the floodplain management measures 

that a community is required either to 

adopt or to show evidence of having in 

effect in order to qualify or remain 

qualified for participation in the Federal 

Emergency Management Agency’s 

(FEMA’s) National Flood Insurance 

Program (NFIP). 

DATES: The date of February 14, 2025 

has been established for the FIRM and, 

where applicable, the supporting FIS 

report showing the new or modified 

flood hazard information for each 

community. 

ADDRESSES: The FIRM, and if 

applicable, the FIS report containing the 

final flood hazard information for each 

community is available for inspection at 

the respective Community Map 

Repository address listed in the tables 

below and will be available online 

through the FEMA Map Service Center 

at https://msc.fema.gov by the date 

indicated above. 

FOR FURTHER INFORMATION CONTACT: Rick 

Sacbibit, Chief, Engineering Services 

Branch, Federal Insurance and 

Mitigation Administration, FEMA, 400 

C Street SW, Washington, DC 20472, 

(202) 646–7659, or (email) 

patrick.sacbibit@fema.dhs.gov; or visit 

the FEMA Mapping and Insurance 

eXchange (FMIX) online at https://

www.floodmaps.fema.gov/fhm/fmx_

main.html. 

SUPPLEMENTARY INFORMATION: The 

Federal Emergency Management Agency 

(FEMA) makes the final determinations 

listed below for the new or modified 

flood hazard information for each 

community listed. Notification of these 

changes has been published in 

newspapers of local circulation and 90 

days have elapsed since that 

publication. The Deputy Associate 

Administrator for Insurance and 

Mitigation has resolved any appeals 

resulting from this notification. 

This final notice is issued in 

accordance with section 110 of the 

Flood Disaster Protection Act of 1973, 

42 U.S.C. 4104, and 44 CFR part 67. 

FEMA has developed criteria for 

floodplain management in floodprone 

areas in accordance with 44 CFR part 

60. 

Interested lessees and owners of real 

property are encouraged to review the 

new or revised FIRM and FIS report 

available at the address cited below for 

each community or online through the 

FEMA Map Service Center at https://

msc.fema.gov. 

The flood hazard determinations are 

made final in the watersheds and/or 

communities listed in the table below. 

(Catalog of Federal Domestic Assistance No. 

97.022, ‘‘Flood Insurance.’’) 

Nicholas A. Shufro, 

Assistant Administrator (Acting) for Risk 

Management, Federal Emergency 

Management Agency, Department of 

Homeland Security. 


lotter on DSK11XQN23PROD with NOTICES1